drugset / Trial / NCT04081402
A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 1/3 Clinical Trial to Evaluate the Safety and Efficacy of HUTOX Compared to Botox® in Subjects With Moderate to Severe Crow's Feet Lines
Timeline
- Start
- 2018-11-01
- Primary completion
- 2019-11
- Completion
- 2020-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | — | — |
| Subject | HU-014 | Unknown | — | — |
Indications
No indication recorded.